NCT06404632

A Group Intervention for Promoting Health-related Habits (LEV-G)

A Group Intervention for Promoting Health-related Habits in Individuals With Disabilities (LEV-G)
Region Stockholm·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov
Study focus
Drug/Device/Intervention
Lev-g
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Region Stockholm
Location
Stockholm, Sweden
Timeline & enrollment
Phase
N/A
Start date
Apr 12, 2024
End date
Dec 31, 2025
Enrollment
30 participants
Primary outcome

Completion rate participants

Summary

Health-related habits influences mental and physical health. Still, treatment of
 health-related habits, which can help to remedy health problems, is often not done at all or
 very superficially. Multiple guidelines emphasize the importance of prioritizing
 health-related habits, but there is a lack of implemented models. To solve this, the
 investigators have developed a transdiagnostic, interprofessional material intended for
 several care settings. The Lev-g intervention is intended for groups. There is also an
 individual version of Lev that has its on registration in Clinical Trails.

ICD-10 classifications
Family history of other disabilities and chronic diseases leading to disablement, not elsewhere classifiedFamily history of certain disabilities and chronic diseases leading to disablementIntentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]Persons with potential health hazards related to family and personal history and certain conditions influencing health statusCare involving use of rehabilitation procedures
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06404632
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06404632 through Pure Global AI's free database. This phase not specified trial is sponsored by Region Stockholm and is currently Recruiting. The study focuses on Life Style,Health-Related Behavior,Disabilities Mental,Disability Physical,Acceptability of Health Care. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.